(Q44718611)

5 December 2017

title

Intralesional injection of herpes simplex virus 1716 in metastatic melanoma (English)

1 reference

5 December 2017

1 reference

R M MacKie

1

1 reference

5 December 2017

B Stewart

series ordinal

2

1 reference

5 December 2017

S M Brown

series ordinal

3

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

5 December 2017

1 reference

5 December 2017

volume

357

1 reference

5 December 2017

issue

9255

1 reference

5 December 2017

page(s)

525-526

1 reference

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904048-4

7 January 2021

Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904048-4

7 January 2021

Treatment of experimental subcutaneous human melanoma with a replication-restricted herpes simplex virus mutant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904048-4

7 January 2021

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2904048-4

7 January 2021

10.1016/S0140-6736(00)04048-4

Identifiers

DOI

1 reference

5 December 2017

1 reference